B12 And Verbal Recall — The Connection Most People Miss
Quick Read Struggling to find a word or remember someone’s name may feel like normal ageing, but research suggests it’s
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
Folate, or vitamin B9, is essential for building DNA and regulating genes through a process called methylation. Your body cannot make it, so you must get it from food or supplements. When folate levels drop, a toxic amino acid called homocysteine builds up and damages brain tissue and blood vessels, which is linked to cognitive decline and dementia. A 2024 study of nearly half a million people found associations between folate supplementation and reduced dementia risk, though this was observational data rather than proof of cause and effect.
The most critical insight from a century of folate research is that folate and vitamin B12 must work together. High-dose folic acid without adequate B12 can mask B12 deficiency, which is common in people over 50 and damages the nervous system silently. Fortification policies and supplement recommendations that address one vitamin without the other are incomplete. Standard supplement doses of folate are safe because excess is excreted in urine.
The biological case for folate protecting the brain is strong and well-understood. However, large-scale clinical trials specifically testing whether folate supplementation prevents dementia in healthy older adults are not yet complete. The sensible approach is to take a daily B complex supplement containing both folate and B12, eat leafy greens and legumes, and consider methylfolate (the pre-converted, biologically active form) if you want to optimize your choice.
Verdict: Folate is a safe, well-researched nutrient essential for brain health, but while the mechanism linking it to dementia prevention is compelling, definitive proof that it prevents cognitive decline in healthy adults is still pending.
It began, as so many great scientific stories do, with a mystery. In the 1920s, doctors watching patients fade from a strange form of anaemia, blood cells bloated and misshapen, too large to do their job properly, had no idea they were witnessing the first chapter of one of medicine’s most enduring research stories. They called it macrocytic anaemia. They had no idea that the same nutrient at its centre would, a century later, be sitting at the heart of our most urgent question in brain health: can we actually prevent dementia? [13]
Here is what decades of research has taught us, and what it means for you today.
Folate, also called vitamin B9, or folic acid in its synthetic supplement form, is not something your body can make itself. You have to get it from food or supplements. [1] And yet it sits at the centre of some of the most fundamental processes in human biology.
The key is something called one-carbon metabolism, a biochemical relay race in which single carbon units are passed between molecules to build DNA, regulate genes through methylation, and synthesise the amino acids your cells need to divide and function. Folate is the engine of that relay. [6] Without it, cells cannot divide properly. That is why deficiency first shows up in rapidly dividing cells, red blood cells in the bone marrow, producing the distinctive oversized, dysfunctional cells of megaloblastic anaemia. [1]
But folate’s most critical partner in this work is vitamin B12. The two vitamins are locked together in a metabolic dance: B12 is required to regenerate the active form of folate, and folate is required for the methylation cycle that B12 also supports. [8] When one is deficient, the other is compromised. This interdependence, elegant in health, dangerous when disrupted, runs through almost every important story in folate research.
One of the most important products of this system is S-adenosylmethionine, or SAMe, the body’s primary methyl donor, responsible for methylating DNA, neurotransmitters, and countless other molecules. [8] When folate and B12 are both working, SAMe flows. When they are not, the methylation cycle stalls, and a toxic amino acid called homocysteine builds up in the blood.
Homocysteine is the villain that connects folate deficiency to neurological disease. It is neurotoxic, damages blood vessels, and has been identified as a significant player in the pathology of cognitive decline, Alzheimer’s disease, and other neurological conditions. [1] [14] Folate, working alongside B6 and B12, is the primary mechanism by which the body converts homocysteine into harmless, useful compounds. [14]
This is the scientific thread that connects a 1920s anaemia ward to a 2024 dementia study of nearly half a million people.
Through the 1950s and 1960s, researchers began piecing together folate’s role beyond anaemia, specifically its involvement in the transfer of single carbon units essential for cell division and DNA synthesis. [13] But it was in the 1960s and 1970s that a more alarming pattern emerged: folate deficiency appeared to be a major, and largely *preventable*, cause of neural tube defects, devastating birth abnormalities like spina bifida affecting the developing spine and brain.
By the early 1990s, well-designed randomised controlled trials confirmed it definitively: periconceptual folate supplementation reduced both the occurrence and recurrence risk of neural tube defects by at least 70%. [13] This was one of the most significant public health findings of the 20th century.
The response was swift. Governments began recommending folic acid supplements for women planning pregnancy, and from the late 1990s the US mandated folic acid fortification of cereal grains, producing an immediate and measurable 20–27% decline in neural tube defects at birth. [13] The UK and many other countries followed similar paths.
Evidence grade: Strong. Multiple RCTs, consistent population-level data, and one of the clearest public health success stories in nutritional science.
This is where folate’s story could have ended, as a pregnancy vitamin. But researchers had only just started asking the next question.
With the neural tube victory secured, attention turned to another emerging signal. Elevated homocysteine, the toxic amino acid that folate, B6 and B12 help to neutralise, was showing up as an independent risk factor not just for neural tube defects, but for cardiovascular disease, stroke, and Alzheimer’s disease. [14]
The logic was compelling: if low folate drives up homocysteine, and high homocysteine damages blood vessels and brain tissue, then correcting folate status should reduce that risk. [1] [14] Reviews from the mid-2000s confirmed that lower levels of folate, B6, and B12 were the primary determinants of high blood homocysteine. [14]
This opened up an entirely new research agenda, using folate (and its B vitamin partners) not just to prevent birth defects, but to protect the ageing brain.
Evidence grade: Promising for the mechanistic link; still accumulating for clinical outcomes in adults.
The homocysteine-brain connection is one of the best-supported biological mechanisms in nutritional neuroscience. The translation into measurable cognitive outcomes is where the picture gets more nuanced, as we will see.
In 2024, researchers published findings from one of the largest nutritional studies ever conducted, a UK Biobank analysis of 466,224 participants examining whether folate and folic acid supplementation was associated with reduced dementia risk. [2] [3]
The scale of this study is genuinely significant. While many supplement trials struggle with small samples and short durations, this analysis had the statistical power to detect meaningful population-level associations. The findings explored folic acid supplementation both alone and in combination with other B vitamins, examining effects on dementia risk and brain structure. [2] [3]
The research prompted enough scientific discussion to generate formal published commentary and a response from the original authors, a sign that the findings were considered both important and worth scrutiny. [2] [3] The broader conversation centred on whether folate supplementation, particularly in combination with other B vitamins, was associated with measurable protective effects on brain health and structure.
Evidence grade: Promising. Observational data from a very large cohort, not an RCT, so causation cannot be established, but the scale of the study gives this more weight than smaller analyses.
Beyond the dementia association data, a 2025 review synthesised the existing evidence for folate’s direct neuroprotective mechanisms, the biological pathways through which adequate folate status may protect brain tissue. [1] [7]
The review highlights several key mechanisms. First, folate’s role in neutralising homocysteine: by converting this neurotoxic amino acid to its harmless form, folate directly reduces neurological damage. Second, folate’s role in DNA methylation, the epigenetic process that regulates gene expression across the entire nervous system. When methylation is impaired, the consequences ripple through neurological function in ways that are still being characterised. [1]
The paper also covers folate’s relevance to neuropsychiatric conditions, depression, anxiety, and cognitive decline, adding to a broader picture of a nutrient whose influence on brain function extends well beyond simple deficiency states. [1]
A 2020 review of folate and ageing-related diseases reinforced this picture, noting associations between folate status and Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, while acknowledging that the underlying mechanisms remain not fully understood and that consistent human trial data is still needed. [10]
Evidence grade: Promising to Early Stage depending on the specific condition. The mechanistic case is strong; the clinical trial evidence in adults is still building.
In 2022, researchers published a case report of an elderly patient with low-folate-related dementia who showed delayed but meaningful improvement in cognitive function after folic acid supplementation. [15]
This is one data point, a single patient, and it cannot tell us that folate supplementation reverses dementia broadly. But case reports have historically been important in folate research: the original concerns about B12-folate interactions were themselves based on case reports from the 1940s. [11] A single well-documented case of cognitive improvement following supplementation in a folate-deficient patient is worth noting, particularly when it fits the biological mechanism so cleanly.
Evidence grade: Traditional/Early Stage. A single case report. Scientifically interesting, not definitive. But it illustrates what the mechanism predicts should happen.
One of the most important, and under-discussed, findings in folate research concerns its relationship with vitamin B12. This is where the history gets genuinely complicated.
In the 1940s, before vitamin B12 was synthesised (this happened in 1948), doctors treating pernicious anaemia with high-dose folic acid observed that the anaemia improved, but some patients’ neurological symptoms worsened. [11] For decades, this created a Tolerable Upper Intake Level for folic acid, a cautious ceiling on supplementation, based on the concern that folate could mask B12 deficiency.
A 2019 re-examination of those historical case reports made an important argument: the neurological deterioration seen in those patients was most likely caused by untreated vitamin B12 deficiency, not by folic acid itself. [11] Before B12 therapy was available, patients with pernicious anaemia had no effective treatment for the neurological damage; folic acid corrected the blood picture but couldn’t address a problem it was never responsible for. The paper argues the historical record does not actually support folic acid as causing neurological complications. [11]
However, more recent evidence introduces a nuance that cannot be ignored. A 2025 paper reviewing 60 years of clinical, epidemiological, and experimental evidence argues that excess folic acid, particularly through the combination of food fortification *and* high-dose supplements, in people with B12 deficiency, may have direct harms to the nervous system. [5] Crucially, the concern is not that folic acid damages everyone; it is that excess folic acid in the presence of *undiagnosed* vitamin B12 deficiency can aggravate the very deficiency it masks, impairing one-carbon metabolic pathways and potentially affecting cortical neurogenesis. [5]
A 2011 National Health and Nutrition Examination Survey analysis found that among participants with low B12 status, high serum folate (above 59 nmol/L) was associated with higher prevalence of anaemia and cognitive impairment compared to those with normal folate levels, and was associated with elevated homocysteine and methylmalonic acid, markers of worsening B12 deficiency. [9]
The 2018 review of folate nutrition echoed this concern: excess folic acid intake has been linked to masking of vitamin B12 deficiency, and questions have been raised about folate-sensitive cancers including colorectal cancer. [6]
The consensus emerging from this body of evidence is not that folate supplementation is harmful. It is that *folate and B12 need to be considered together*, that the balance between the two is crucial, and that fortification policies and supplement recommendations that address one without the other are incomplete. [5] [9]
It would be dishonest to wrap this story in a neat bow. Here is where the science is genuinely uncertain, and why.
The dementia question is still open. The UK Biobank analysis of 466,224 participants is observational data, it shows associations, not causation. [2] [3] People who take B vitamin supplements may differ from those who do not in dozens of other ways, diet, health engagement, socioeconomic status, that could explain the association. What we need are large, long-duration randomised controlled trials specifically designed to test whether folate (with B12) meaningfully slows cognitive decline in healthy older adults. Those trials are not yet complete.
Why study results conflict. The 2020 review noted a “lack of consistent data” across cognitive studies, and the reasons are important to understand rather than dismiss. [10] Studies differ in: the form of folate used (synthetic folic acid versus natural food folate versus methylfolate, the biologically active form); the baseline folate status of participants (supplementing people who are already replete may show different results to correcting deficiency); the duration of supplementation; the age and health of participants; and whether B12 and B6 were co-administered. Different studies using different doses in different populations at different stages of cognitive ageing will inevitably produce different results, that is not evidence that folate doesn’t matter, it is evidence that the details matter enormously. [10]
The excess folic acid question. Whether high-dose synthetic folic acid supplementation (particularly through combined fortification and supplements) causes harm in people with low B12 is a live scientific debate. The evidence is suggestive enough to take seriously, but the 2019 historical review challenges some of the foundational case reports. [11] More long-term prospective studies are needed.
The genetic dimension. We know that genetic variants in folate metabolism, particularly MTHFR polymorphisms, which affect how efficiently the body converts folic acid to its active form, influence how individuals respond to supplementation. [13] This means population averages in trials may obscure large individual differences. This is an area where personalised nutrition science needs to catch up.
The methylfolate advantage. There is growing discussion of whether methylfolate (5-MTHF), the biologically active, already-converted form, may be preferable to synthetic folic acid, particularly for people with MTHFR variants. The 2025 paper notes the potential benefits of “a natural reduced folate” over synthetic folic acid in fortification. [5] Human trial evidence comparing the two directly in cognitive outcomes is limited.
Here is the honest summary of what a century of folate research has given us, and what a sensible, informed person should actually do with it.
The big picture is positive. Folate is a nutrient with one of the longest, most intensively studied track records in nutritional science. We know with certainty that it is essential for brain function, DNA synthesis, and the methylation processes that regulate gene expression across the entire nervous system. We know that deficiency is genuinely harmful, not just to developing babies, but to ageing brains. [1] [13] We know that it works in concert with vitamin B12 and B6 to keep homocysteine in check, and that high homocysteine is associated with cognitive decline and dementia risk. [14]
Folate is a water-soluble B vitamin. Excess is excreted in urine. At normal dietary and supplement doses, typically 400–800 mcg, it is safe. The risk of common deficiency almost certainly outweighs the risk of supplementing at standard doses. Supplement daily; it is safe and excess is excreted.
The B12 partnership matters. The most important practical lesson from this research is this: folate and B12 should be considered together, not in isolation. [5] [9] If you are supplementing with folate, or eating a diet fortified with folic acid, make sure your B12 intake is adequate. B12 deficiency is extremely common in people over 50 (due to declining stomach acid and absorption efficiency), it progresses silently, and it can be made worse if high folate masks its early warning signs. A good B complex supplement that includes both folate and B12 is the most rational approach. [8]
For cognitive health specifically: the evidence is promising but not yet definitive. The biological mechanism is one of the best-characterised in nutritional neuroscience. A large-scale study of nearly 500,000 people shows interesting associations. [2] [3] But we do not yet have the RCT evidence to say with confidence that supplementing folate in cognitively healthy adults over 50 will prevent dementia. What we *can* say is that deficiency is harmful, that homocysteine management matters, and that the risk/benefit calculation for a safe, inexpensive B complex supplement strongly favours taking it.
Consider methylfolate. If you want to be thoughtful about form, methylfolate (5-MTHF), the pre-converted, biologically active form, may be preferable for some people, particularly those with MTHFR gene variants that reduce their ability to convert standard folic acid. [5] It is not dramatically more expensive, and the downside risk is essentially zero.
What would a sensible, informed person actually do?
Take a daily B complex containing folate (ideally as methylfolate), B12 (ideally as methylcobalamin), and B6. Eat plenty of leafy greens and legumes, the best natural sources of food folate. If you are over 50, consider having your B12 levels checked at least once, since absorption declines with age and deficiency is common. Beyond that, do not overcomplicate it. This is one of the most evidence-backed, safest, and cheapest interventions in brain health nutrition, with a research history stretching back a century.
Vitacuity analysed over 1.77 million research papers to bring you the most relevant evidence on this topic. The folate story is one of science’s great journeys, from a mysterious blood disorder in the 1920s to one of our best-understood nutritional mechanisms for brain health in 2025. The journey is not over. But what we know today is already worth acting on.
[1] Neuroprotective Effects of Folic Acid: A Review (2025). DOI: 10.1080/19390211.2024.2436842 | https://pubmed.ncbi.nlm.nih.gov/39648692/
[2] Discussing “Associations of Folate/Folic Acid Supplementation Alone and in Combination With Other B Vitamins on Dementia Risk and Brain Structure” (2024). https://pubmed.ncbi.nlm.nih.gov/38949211/
[3] Response to the Comment on “Associations of Folate/Folic Acid Supplementation Alone and in Combination With Other B Vitamins on Dementia Risk and Brain Structure: Evidence From 466,224 UK Biobank Participants” (2024). DOI: 10.1093/gerona/glae124 | https://pubmed.ncbi.nlm.nih.gov/39360885/
[4] Folic Acid Supplementation on Congenital Heart Disease and Its Dual Character (2025). DOI: 10.1016/j.crphar.2025.100222 | https://pubmed.ncbi.nlm.nih.gov/40487591/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144426/
[5] Fortification, Folate and Vitamin B12 Balance, and the Nervous System. Is Folic Acid Excess Potentially Harmful? (2025). DOI: 10.1038/s41430-025-01652-8 | https://pubmed.ncbi.nlm.nih.gov/40813465/
[6] Recent Developments in Folate Nutrition (2018). https://pubmed.ncbi.nlm.nih.gov/29477222/
[7] Neuroprotective Effects of Folic Acid: A Review (2025). DOI: 10.1080/19390211.2024.2436842 | https://pubmed.ncbi.nlm.nih.gov/39648692/
[8] Folate, Vitamin B₁₂, and S-Adenosylmethionine (2013). https://pubmed.ncbi.nlm.nih.gov/23538072/
[9] Folic Acid Fortification: Why Not Vitamin B12 Also? (2011). https://pubmed.ncbi.nlm.nih.gov/21674649/
[10] An Appraisal of Folates as Key Factors in Cognition and Ageing-Related Diseases (2020). DOI: 10.1080/10408398.2018.1549017 | https://pubmed.ncbi.nlm.nih.gov/30729795/
[11] Lack of Historical Evidence to Support Folic Acid Exacerbation of the Neuropathy Caused by Vitamin B12 Deficiency (2019). DOI: 10.1093/ajcn/nqz089 | https://pubmed.ncbi.nlm.nih.gov/31187858/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785032/
[12] Discussing “Associations of Folate/Folic Acid Supplementation Alone and in Combination With Other B Vitamins on Dementia Risk and Brain Structure” (2024). https://pubmed.ncbi.nlm.nih.gov/38949211/
[13] Chapter 30: Historical Aspects of the Major Neurological Vitamin Deficiency Disorders: The Water-Soluble B Vitamins (2010). https://pubmed.ncbi.nlm.nih.gov/19892133/
[14] Vitamins and Minerals 4: Overview of Folate and the B Vitamins (2006). https://pubmed.ncbi.nlm.nih.gov/16780289/
[15] Delayed Improvement of Cognitive Function After Folic Acid Supplementation in an Elderly Patient With Low Folate Levels-Related Dementia: A Case Report (2022). DOI: 10.1111/psyg.12796 | https://pubmed.ncbi.nlm.nih.gov/34918853/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Struggling to find a word or remember someone’s name may feel like normal ageing, but research suggests it’s
Quick Read Chronic loneliness, the subjective feeling that your relationships don’t match what you need, physically damages your brain. Research
Free guide: The research behind brain health supplements
Plus our weekly research digest — straight to your inbox.
Just leave your email address.